| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/25/2009 | CN100471855C Oxetane compounds containing maleimide functional group |
| 03/25/2009 | CN100471845C C 10 ester substituted taxadane |
| 03/25/2009 | CN100471842C Quinolone derivative or its salt |
| 03/25/2009 | CN100471832C Compound for preparing protease inhibitor |
| 03/24/2009 | US7507839 e,g, 1,5-bis(5-acetyl-4,7-dimethoxybenzofuran-6-yloxy)pentane;potassium channel modulator; antiinflammatory agent, autoimmune diseases; immunosuppressant; multiple sclerosis, rejection of foreign organ transplants |
| 03/24/2009 | US7507815 Succinoylamino lactams as inhibitors of a-β protein production |
| 03/24/2009 | US7507762 Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2009 | US7507761 Benzopyran derivatives, method of production and use thereof |
| 03/24/2009 | US7507754 e.g. N-{4-[4-(5-Methoxy-pyridin-2-yl)-phenoxymethyl]-5-methyl-furan-2-carbonyl}-2-methyl-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 03/24/2009 | US7507753 Biaryl compound and use thereof |
| 03/24/2009 | US7507751 Biphenyl derivatives |
| 03/24/2009 | US7507747 Muscarinic acetylcholine receptor antagonists |
| 03/24/2009 | US7507741 Heterocyclic compounds |
| 03/24/2009 | US7507734 Pyridazinone derivatives |
| 03/24/2009 | US7507420 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/24/2009 | CA2224060C Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 03/19/2009 | WO2009035652A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
| 03/19/2009 | WO2009035067A1 Glucocorticoid receptor agonists consisting of 1,3,3-tri- methyl-7-phenyl-3,4-dihydro-1h-quinoxalin-2-one derivatives |
| 03/19/2009 | WO2009034258A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 03/19/2009 | WO2009033703A1 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| 03/19/2009 | WO2009002510A3 Crystalline polymorph of exemestane |
| 03/19/2009 | WO2009002489A3 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 03/19/2009 | WO2008157552A3 Invertebrate acetylcholinesterase inhibitors |
| 03/19/2009 | WO2008116107A3 Piperazine derivatives as glucokinase activators |
| 03/19/2009 | US20090076281 Process for the preparation of losartan and its salts |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076274 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders |
| 03/19/2009 | US20090076103 Stem cell differentiating agents and uses therefor |
| 03/19/2009 | US20090076091 Indazole-heteroaryl derivatives |
| 03/19/2009 | US20090076088 Thrombin Receptor Antagonists |
| 03/19/2009 | US20090076077 Methods and Compositions for Selectin Inhibition |
| 03/19/2009 | US20090076030 Piperazine compounds |
| 03/19/2009 | US20090076004 1-Aryl-or heteroaryl-3-aryl-or heteroarylindole-2-carboxylic acids or esters: e.g., 5-(4-tert-Butylphenyl)-1,3-bis(4-isopropoxyphenyl)-indole-2-carboxylic acid; inhibition of the activity of microsomal prostaglandin E synthase-1, leukotriene C4 and/or 5-lipoxygenase-activating protein; analgesics |
| 03/19/2009 | US20090076003 Phthalazine Derivatives with Angiogenesis Inhibiting Activity |
| 03/19/2009 | US20090075253 Bioreactive agents |
| 03/19/2009 | DE102007044277A1 Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln Substituted nicotinamide compounds and their use in medicaments |
| 03/19/2009 | CA2698929A1 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones |
| 03/19/2009 | CA2698808A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof |
| 03/19/2009 | CA2698792A1 Vegfr inhibitors containing a zinc binding moiety |
| 03/19/2009 | CA2692702A1 Tri-amino-pyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors |
| 03/18/2009 | EP2036904A1 A process for the preparation of olmesartan medoxomil |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP2035415A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 03/18/2009 | EP2035414A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 03/18/2009 | EP2035412A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 03/18/2009 | EP2035411A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia. |
| 03/18/2009 | EP2035407A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 03/18/2009 | EP2035406A1 Novel substituted-1h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 03/18/2009 | EP2035396A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP2035394A1 2-pyrazinecarboxamide derivatives |
| 03/18/2009 | EP2035391A1 Indazole derivatives for treating hsp90-induced diseases |
| 03/18/2009 | EP2035387A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 03/18/2009 | EP2035386A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 03/18/2009 | EP2035384A2 Process for synthesizing piperazine-piperidine compounds |
| 03/18/2009 | EP2035380A2 Parp inhibitors |
| 03/18/2009 | EP2035378A1 Substituted isoindoles as bace inhibitors and their use |
| 03/18/2009 | EP2035377A1 Indole derivatives and their use as thyroid receptor ligands |
| 03/18/2009 | EP2035375A1 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments |
| 03/18/2009 | EP2035372A1 Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 03/18/2009 | EP2034996A2 Triazole compounds that modulate hsp90 activity |
| 03/18/2009 | EP1824486B1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 03/18/2009 | EP1656346B1 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases |
| 03/18/2009 | EP1567493B1 Phenyl substituted piperidine compounds for use as ppar activators |
| 03/18/2009 | EP1558603A4 Oxyge-containing heterocyclic fused naphthopyrans |
| 03/18/2009 | EP1539151B1 Biaryl compounds having anti-infective activity |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/18/2009 | CN101389622A Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 03/18/2009 | CN101389608A 5-HT7 receptor antagonists |
| 03/18/2009 | CN100469779C Inhibitors of interleukin-1beta converting enzyme |
| 03/18/2009 | CN100469776C Amelioration of the development of cataracts and other ophthalmic diseases |
| 03/18/2009 | CN100469769C Benzyl-pyridazinons as reverse transcriptase inhibitors |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/17/2009 | USRE40667 [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 03/17/2009 | US7504537 osteoarthritis or rheumatoid arthritis |
| 03/17/2009 | US7504522 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction |
| 03/17/2009 | US7504511 e.g. N-[4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl]-4((4-[2-(S)-(hydroxymethyl)pyrrolidin-1-yl]piperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agent |
| 03/17/2009 | US7504508 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/17/2009 | US7504489 enzyme inhibitors such as beta-1'-nicotinamide-2'-deoxyribose, used for treating diseases and conditions associated with CD38, related enzymes and cyclic-adenosine-diphosphate-ribose (cADPR) |
| 03/17/2009 | US7504436 Bioisosteres of actinonin |
| 03/17/2009 | US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504410 such as N-[3-[[5-bromo-4-[[3-[[[1-(trifluoromethyl)cyclobutyl]carbonyl]amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide; Chks (checkpoint kinases), Akts (protein kinases B) and Pdks (phosphoinositide-dependent kinases) inhibitors; antiproliferative agents |
| 03/17/2009 | US7504408 Quinzoline derivatives for use in the treatment of cancer |
| 03/17/2009 | US7504402 bicyclo[2.2.2]-oct-1-yl-1,2,4-triazoles; type 2 diabetes, lipid disorders, obesity, atherosclerosis, metabolic syndrome, hyperglycemia, insulin resistance; increase insulin sensitivity in muscle, liver and adipose tissue by correction of the elevated plasma levels of glucose without causing hypoglycemia |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504362 Pesticidal compositions |
| 03/17/2009 | US7504360 Containing crystalline compounds which produce color when thermally converted to liquid or amorphous form time-independent |
| 03/17/2009 | US7504243 Methods for the production of biliverdin |
| 03/17/2009 | US7504087 Receptor-avid exogenous optical contrast and therapeutic agents |
| 03/17/2009 | CA2717039A1 Catalytic process for asymmetric hydrogenation |
| 03/17/2009 | CA2360668C The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 03/17/2009 | CA2337849C Piperazinone derivatives and applications thereof |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |